This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
In hospital settings, the success of AI adoption hinges on how well implementation leaders balance technological innovation in departmental silos with operational nimbleness across the enterprise. In a term, the latter refers to hospital logistics.
The AI revolution in healthcare is less about technological advancement than change management vis-à-vis human relations. This may be nowhere more true than in critical care.
Primary care providers are excited about the promise AI holds to help them help patients living with multiple chronic conditions. However, they believe these patients will continue to need the human connection they get from their PCPs.
Philips is recalling all sizes of its Tack Endovascular System after 20 patient injuries were reported. Interventional cardiologists are urged to stop using the device immediately.
Fewer than one-third of primary care clinicians have a say in selecting the AI products their institutions expect them to fold into their clinical workflows. That’s a problem.
Generative AI is altering the way healthcare consumers size up hospitals, group practices and individual providers. But the comparison shopping would pose a challenge to healthcare organizations even if AI hadn’t entered the picture.
No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.”
Two in five practicing physicians are equal parts enthused over and worried about AI in healthcare. That’s the same ratio the American Medical Association turned up the last time it conducted its Physician Sentiment Survey.
An international cluster of 117 researchers from 50 countries has arrived at a consensus on six principles that, in the team’s considered view, ought to guide the use of AI across healthcare worldwide.
Heartflow, known for its AI-based CCTA evaluations, appears to be going public. The news follows years of momentum for the California-based company, including improved Medicare reimbursements for cardiac CT and a new Category I CPT code for its Plaque Analysis software.
Suman Tandon, MD, an American Society of Nuclear Cardiology board member, explains the group's call on Congress to update a number of healthcare policies.
The 2026 MPFS proposed rule includes higher conversion factors across the board. However, some cardiology groups remain concerned about a series of reimbursement reductions for high-value cardiology services.
